Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats

EJ Rahn, AM Zvonok, GA Thakur, AD Khanolkar… - … of Pharmacology and …, 2008 - ASPET
Activation of cannabinoid CB2 receptors suppresses neuropathic pain induced by traumatic
nerve injury. The present studies were conducted to evaluate the efficacy of cannabinoid …

[引用][C] Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in …

EJ Rahn, AM Zvonok, GA Thakur… - … of Pharmacology and …, 2008 - cir.nii.ac.jp
Selective Activation of Cannabinoid CB<sub>2</sub> Receptors Suppresses Neuropathic
Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats | CiNii …

Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats.

EJ Rahn, AM Zvonok, GA Thakur… - The Journal of …, 2008 - europepmc.org
Activation of cannabinoid CB 2 receptors suppresses neuropathic pain induced by traumatic
nerve injury. The present studies were conducted to evaluate the efficacy of cannabinoid CB …

[引用][C] Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in …

EJ Rahn, AM Zvonok, GA Thakur, AD Khanolkar… - … of Pharmacology and …, 2008 - ASPET
Activation of cannabinoid CB2 receptors suppresses neuropathic pain induced by traumatic
nerve injury. The present studies were conducted to evaluate the efficacy of cannabinoid …

[PDF][PDF] Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in …

EJ Rahn, AM Zvonok, GA Thakur… - J Pharmacol Exp …, 2008 - researchgate.net
Activation of cannabinoid CB2 receptors suppresses neuropathic pain induced by traumatic
nerve injury. The present studies were conducted to evaluate the efficacy of cannabinoid …

[PDF][PDF] Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in …

EJ Rahn, AM Zvonok, GA Thakur, AD Khanolkar… - 2008 - Citeseer
Activation of cannabinoid CB2 receptors suppresses neuropathic pain induced by traumatic
nerve injury. The present studies were conducted to evaluate the efficacy of cannabinoid …

[HTML][HTML] Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel …

EJ Rahn, AM Zvonok, GA Thakur… - The Journal of …, 2008 - ncbi.nlm.nih.gov
Activation of cannabinoid CB 2 receptors suppresses neuropathic pain induced by traumatic
nerve injury. The present studies were conducted to evaluate the efficacy of cannabinoid CB …

Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats

EJ Rahn, AM Zvonok, GA Thakur… - The Journal of …, 2008 - pubmed.ncbi.nlm.nih.gov
Activation of cannabinoid CB (2) receptors suppresses neuropathic pain induced by
traumatic nerve injury. The present studies were conducted to evaluate the efficacy of …

[PDF][PDF] Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in …

EJ Rahn, AM Zvonok, GA Thakur, AD Khanolkar… - THE JOURNAL OF …, 2008 - Citeseer
Activation of cannabinoid CB2 receptors suppresses neuropathic pain induced by traumatic
nerve injury. The present studies were conducted to evaluate the efficacy of cannabinoid …

Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats.

EJ Rahn, AM Zvonok, GA Thakur… - The Journal of …, 2008 - europepmc.org
Activation of cannabinoid CB 2 receptors suppresses neuropathic pain induced by traumatic
nerve injury. The present studies were conducted to evaluate the efficacy of cannabinoid CB …